Formula1.jpg (Formula1)
Haloperidol Lactate Injection, Solution
Product Images NDC 0404-9871
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Haloperidol Lactate (NDC 0404-9871). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image1.jpg (Image1)
This text warns about an increased risk of mortality in elderly patients with dementia-related psychosis who are treated with antipsychotic drugs. It cites seventeen placebo-controlled trials which showed that drug-treated patients carried a risk of death 1.6 to 1.7 times greater than placebo-treated patients. Most deaths seemed to be due to cardiovascular or infectious nature. Although observational studies suggest that conventional antipsychotic drugs may also cause increased mortality, it is not clear whether mortality is caused by the drugs themselves or by patient characteristics. The use of Haloperidol injection is not approved for the treatment of patients with dementia-related psychosis.*
Image2.jpg (Image2)
This is a report on the adverse reactions observed in a clinical trial comparing the effects of oral Waloperidol and a placebo. The trial involved 288 participants who reported adverse reactions that were classified based on affected systems or organs and reported frequencies. The most frequently reported adverse reactions for oral Waloperidol were extrapyramidal disorders (including hyperkinesia, tremor, hypertoria, dystonia, and bradykinesia), constipation, and somnolence. The most frequently reported adverse reactions for the placebo were constipation, dry mouth, and tremor.*
Label1.jpg (Label1)
Haloperidol injection is a sterile medication provided in a single-dose vial, meant only for IM use and must be kept away from children's reach. It must be kept protected from light, and it should not be frozen. It must be stored at controlled room temperature, between 63 to 77 degrees Fahrenheit. Dispensing must be done using light-resistant containers as defined in the official compendium. The package is from Henry Schein, Inc., located in Dastian, VA. The manufacturer's insert contains complete product information and prescribing format. The item number is 2460878, and the NDC number is 67457 426 12. The GTIN number is (01)X0000000C0000C, the SER number is {21)100000000000K, the lot number is (10))00000ยข, and the EXP number is (17))00000C.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
